# Aventis Pharma Manufacturing Pte. Ltd. – FDA Inspection, Oct 13, 2017

Source: https://www.keypedia.com/records/fda_inspections/aventis-pharma-manufacturing-pte-ltd/808e1341-af4e-42e2-ba43-6014e4f202f5
Source feed: FDA_Inspections

> FDA inspection 1032305 of Aventis Pharma Manufacturing Pte. Ltd., October 13, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1032305
- Company Name: Aventis Pharma Manufacturing Pte. Ltd.
- Inspection Date: 2017-10-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1274305 - 2025-06-13](https://www.keypedia.com/records/fda_inspections/aventis-pharma-manufacturing-pte-ltd/7dbfd7cf-4667-4737-b33f-3f590fac3541)
- FDA Inspection 1113084 - 2019-11-01
- FDA Inspection 933845 - 2015-05-22
- FDA Inspection 773423 - 2012-03-09
- FDA Inspection 677605 - 2010-07-15

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/camerson-e-moore/50733244-0d55-4b0b-a758-f192b7c66457)

Company: https://www.keypedia.com/companies/aventis-pharma-manufacturing-pte-ltd/65533898-b50d-45f9-ac39-9f6158becf7e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c